Radiother Oncol 2023 Aug
From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial.
Related Questions
New comment by Radiation Oncologist at Memorial Sloan Kettering Cancer Center ( November 25, 2024)
Agreed. Also, STAMPEDE allowed weekly fractionation. I think you can let patients and/or therapy workflows drive the choice (e.g. if the patient only can come one day a week o...